1. Home
  2. SMBK vs CSTL Comparison

SMBK vs CSTL Comparison

Compare SMBK & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMBK
  • CSTL
  • Stock Information
  • Founded
  • SMBK N/A
  • CSTL 2007
  • Country
  • SMBK United States
  • CSTL United States
  • Employees
  • SMBK N/A
  • CSTL N/A
  • Industry
  • SMBK Major Banks
  • CSTL Medical Specialities
  • Sector
  • SMBK Finance
  • CSTL Health Care
  • Exchange
  • SMBK Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • SMBK 538.6M
  • CSTL 568.2M
  • IPO Year
  • SMBK N/A
  • CSTL 2019
  • Fundamental
  • Price
  • SMBK $28.88
  • CSTL $21.51
  • Analyst Decision
  • SMBK Buy
  • CSTL Strong Buy
  • Analyst Count
  • SMBK 6
  • CSTL 6
  • Target Price
  • SMBK $30.50
  • CSTL $40.00
  • AVG Volume (30 Days)
  • SMBK 60.0K
  • CSTL 330.2K
  • Earning Date
  • SMBK 04-21-2025
  • CSTL 05-05-2025
  • Dividend Yield
  • SMBK 1.11%
  • CSTL N/A
  • EPS Growth
  • SMBK 26.63
  • CSTL N/A
  • EPS
  • SMBK 2.14
  • CSTL 0.62
  • Revenue
  • SMBK $166,349,000.00
  • CSTL $332,069,000.00
  • Revenue This Year
  • SMBK $19.20
  • CSTL N/A
  • Revenue Next Year
  • SMBK $9.76
  • CSTL $3.34
  • P/E Ratio
  • SMBK $13.45
  • CSTL $34.69
  • Revenue Growth
  • SMBK 11.36
  • CSTL 51.09
  • 52 Week Low
  • SMBK $19.01
  • CSTL $16.97
  • 52 Week High
  • SMBK $37.72
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • SMBK 43.06
  • CSTL 56.26
  • Support Level
  • SMBK $26.84
  • CSTL $18.03
  • Resistance Level
  • SMBK $28.77
  • CSTL $20.77
  • Average True Range (ATR)
  • SMBK 1.22
  • CSTL 1.27
  • MACD
  • SMBK 0.07
  • CSTL 0.41
  • Stochastic Oscillator
  • SMBK 51.09
  • CSTL 93.06

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: